On Friday, Shares of Whole Foods Market, Inc. (NASDAQ:WFM), gained 0.89% to $36.40, hitting its lowest level.
Whole Foods Market declared that Jason Buechel has been promoted from global vice president and chief information officer to executive vice president and chief information officer, becoming the newest member of the executive team effective right away.
Buechel retains responsibility for all aspects of information technology at Whole Foods Market.
“Technology is essential to our customer experience, our team member experience, our ability to compete, and our ability to effectively deliver return on invested capital,” said Glenda Flanagan, executive vice president and chief financial officer of Whole Foods Market. “Jason has made noteworthy contributions to improve our front- and back-end technology, and we believe it is essential for this vital element of our business to be represented at the executive decision-making level.”
Since joining Whole Foods Market in 2012, Buechel has continuously improved the Company’s information technology infrastructure, launching several new major platforms and initiatives such as Workday, One POS, the Company’s pilot Affinity shopper rewards program, and delivery partnership with Instacart.
Whole Foods Market, Inc. operates as a retailer of natural and organic foods. The company’s stores offer produce and floral, grocery, meat, seafood, bakery, prepared foods and catering, coffee, tea, beer, wine, cheese, nutritional supplements, vitamins, and body care products, in addition to lifestyle products, counting books, pet products, and household products.
Shares of Exelixis, Inc. (NASDAQ:EXEL), inclined 3.43% to $5.73, during its last trading session.
Exelixis declared that its second quarter 2015 financial results will be released on Tuesday, August 11, 2015 after the markets close. At 5:00 p.m. EDT / 2:00 p.m. PDT, Exelixis administration will host a conference call to talk about the results and provide a general business update. The conference call will be accessible via the Internet from the company’s website.
Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patients with progressive, metastatic medullary thyroid cancer.
Finally, CONSOL Energy Inc. (NYSE:CNX), ended its last trade with -1.96% loss, and closed at $16.52.
CONSOL Energy Board of Directors declared a regular quarterly dividend of $0.01 per share, payable on August 24, 2015, to shareholders of record on August 10, 2015.
CONSOL Energy Inc., together with its auxiliaries, operates as an integrated energy company in the United States and internationally. The company operates through two divisions, Exploration and Production (E&P), and Coal.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
